ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,397Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 61

$667K Total Retail Price of All Prescriptions

Rank: 3 out of 61

533 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 9,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
ATORVASTATIN CALCIUM 624 527 1 7
LISINOPRIL 609 453 2 2
AMLODIPINE BESYLATE 602 521 3 5
ISOSORBIDE MONONITRATE ER 591 468 4 12
METOPROLOL SUCCINATE 495 426 5 6
HYDRALAZINE HCL 467 407 6 19
FUROSEMIDE 462 370 7 9
WARFARIN SODIUM 444 374 8 11
METOPROLOL TARTRATE 387 289 9 4
CARVEDILOL 362 250 10 1
CRESTOR 349 275 11 14
CLOPIDOGREL 345 270 12 3
PRAVASTATIN SODIUM 298 267 13 13
PLAVIX 285 220 14 10
DIGOXIN 283 204 15 15
LOSARTAN POTASSIUM 245 195 16 17
ZETIA 233 151 17 23
CILOSTAZOL 194 154 18 44
HYDROCHLOROTHIAZIDE 188 158 19 16
RANEXA 176 106 20 28
PANTOPRAZOLE SODIUM 162 140 21 25
DIOVAN 150 137 22 22
PROPAFENONE HCL 140 110 23 66
TRICOR 130 84 24 46
GEMFIBROZIL 126 73 25 73
FENOFIBRATE 124 95 26 47
LIPITOR 120 96 27 27
TRILIPIX 110 91 28 82
LOVASTATIN 108 95 29 57
LOVAZA 99 77 30 41
DOXAZOSIN MESYLATE 99 96 30 48
POTASSIUM CHLORIDE 99 71 30 21
NIASPAN 98 96 33 26
RANITIDINE HCL 92 80 34 56
DILTIAZEM 24HR ER 86 64 35 52
OMEPRAZOLE 86 35 35 37
KLOR-CON M20 82 69 37 31
SOTALOL 80 52 38 29
SPIRONOLACTONE 74 54 39 32
COUMADIN 72 72 40 54
VERAPAMIL ER 70 67 41 60
AMIODARONE HCL 68 61 42 36
ATENOLOL 67 58 43 18
CLONIDINE HCL 64 48 44 42
BENAZEPRIL HCL 60 60 45 53
SIMVASTATIN 56 48 46 8
ENALAPRIL MALEATE 52 52 47 64
EFFIENT 50 38 48 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.